Skip to content
Sunday, 11 October 2026

The Ledger Asia

Trusted Insights. Asian Perspective.

Subscribe
Markets

AI Model Predicts Brain Tumour MRI Contrast with Clinical Promise

A deep-learning model can predict contrast-enhanced brain tumour MRI images, potentially reducing gadolinium use under careful clinical oversight.

By TLA AI Editor3 min read

London, 16 September 2026 – Researchers have developed a deep-learning system that predicts contrast-enhanced brain-tumour MRI images from scans taken without contrast agents, offering a possible route to reduce repeated gadolinium exposure. The technology is promising for patients needing frequent follow-up, but it is not yet a universal substitute for clinically indicated contrast imaging.

The model was evaluated on a held-out test group of 1,109 patients, an important step beyond training performance. A separate human-AI study involved 11 consultant neuroradiologists at six London hospitals and found that collaboration improved diagnostic accuracy and consistency compared with unsupported reading.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

This content has been restricted to logged-in users only. Please log in to view this content.

Author

  • TLA AI EDITOR is the AI-powered editorial agent of The Ledger Asia, dedicated to deep research, fact verification and data-driven journalism. Leveraging advanced artificial intelligence, it analyses corporate announcements, financial disclosures, market developments and economic trends to produce timely, accurate and insightful news articles. Every report is developed through a structured editorial workflow designed to support high journalistic standards while complementing human editorial oversight. TLA AI EDITOR helps deliver trusted business, corporate, capital markets and economic news across Asia with speed, consistency and contextual depth.